TITANBIOTitan Bio-Tech Ltd.
Titan Bio-Tech Q2 FY27 Results: Consolidated Net Profit ₹12.55 Crore
- Earnings
Reviewed byKeshav SehgalBlacklitt Research
Titan Bio-Tech reported consolidated net profit of ₹12.55 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹78.18 crore and standalone net profit of ₹11.33 crore, in a filing on 05 Nov 2026.
Key highlights
Consolidated
Including its subsidiaries
- Net profit: ₹12.55 crore, up 61.6% YoY and 15.6% QoQ
- Profit before tax: ₹15.13 crore, up 64.1% YoY and 18.8% QoQ
- Other income: ₹1.72 crore, up 29.9% YoY and down 5.1% QoQ
Standalone
The company on its own, without its subsidiaries
- Total income: ₹78.18 crore, up 28.2% on the quarter before (₹60.98 crore)
- Net profit: ₹11.33 crore, up 65.1% YoY and 19.8% QoQ
- EPS: ₹2.74 basic, against ₹2.29 in the quarter before
- Finance costs: ₹0.28 crore, against ₹0.20 crore in the quarter before
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Other income | 1.72 | 1.32 | +29.9% | 1.81 | -5.1% |
| 12.55 | 7.76 | +61.6% | 10.86 | +15.6% | |
| Profit before tax | 15.13 | 9.22 | +64.1% | 12.73 | +18.8% |
| Depreciation | 1.32 | 1.21 | +9.5% | 1.37 | -3.1% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Consolidated net profit rose 61.6% year on year, slower than profit before tax, which rose 64.1%. Other income of ₹1.72 crore was 11.4% of profit before tax of ₹15.13 crore for the quarter.
The consolidated results include the associate companies Peptech Biosciences Limited and Titan Media Limited. The auditors' review says the associates' share of net profit after tax was ₹1.22 crore (₹121.66 lacs) for the quarter, based on the associates' interim results, which the auditors reviewed. Their conclusion is not modified in respect of this matter.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 78.18 | n/a | n/a | 60.98 | +28.2% | |
| Revenue from operations | 76.46 | n/a | n/a | 59.17 | +29.2% |
| Other income | 1.72 | 1.32 | +29.9% | 1.81 | -5.1% |
| 11.33 | 6.86 | +65.1% | 9.46 | +19.8% | |
| Profit before tax | 15.13 | 9.22 | +64.1% | 12.73 | +18.8% |
| Finance costs | 0.28 | n/a | n/a | 0.20 | +40.7% |
| Depreciation | 1.32 | 1.21 | +9.5% | 1.37 | -3.1% |
| Tax expense | 3.80 | 2.36 | +61.1% | n/a | n/a |
| EPS, basic (₹) | 2.74 | n/a | n/a | 2.29 | +19.7% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit of ₹11.33 crore rose 65.1% year on year, faster than profit before tax, which rose 64.1%. From the quarter before, net profit rose 19.8%, slower than total income, which rose 28.2%.
Standalone tax expense of ₹3.80 crore is 25.1% of profit before tax of ₹15.13 crore. Finance costs rose to ₹0.28 crore from ₹0.20 crore in the quarter before, which is 0.4% of total income. Basic EPS was ₹2.74 against ₹2.29 in the quarter before.
Inference
A separate filing on 26 Oct 2026 said the company allotted fully paid bonus equity shares of ₹2 each to shareholders holding shares on the record date of 23 Oct 2026. Paid-up equity share capital was ₹8.26 crore at 30 Sep 2026.
The auditors' limited review of the standalone and consolidated results says nothing has come to their attention that causes them to believe the statements contain a material misstatement.
The filing does not state the reason for the rise in profit this quarter.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
